跳至主要内容
临床试验/CTRI/2023/05/053117
CTRI/2023/05/053117尚未招募3 期

TO VERIFY CLINICAL UTILITY OF RUBRICS OF RINGWORM FROM KNERR REPERTORY: INTERVENTIONAL UNCONTROLLED TRIAL

KHUSHALI KUBERBHAI PATEL1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年3月6日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
34
试验地点
1
主要终点
RINGWORM SYMPTOM SCORE

研究概览

简要总结

SKIN DISEASES ARE MAJOR HEALTH PROBLEM AFFECTING A HIGH PROPORTION OF POPULATION OF INDIA SKIN DISEASE CAN PLACE A HEAVY EMOTIONAL AND PSYCHOLOGICAL BURDEN ON PATIENTS THAT MAY BE FAR WORSE THAN PHYSICAL IMPACT THE STUDY WILL BE EXPERIMENTAL AND INTERVENTIONAL UNCONTROLLED TRIAL A STUDY WILL BE CONDUCTED WITH 34 SAMPLES AND WHICH WILL BE SELECTED FROM 2 PROJECT SITE ON BASIS OF INCLUSION AND EXCLUSION CRITERIA THROUGH PURPOSIVE SAMPLING CONSENT WILL BE TAKEN OF CHOSEN CASES CASE TAKING WILL BE DONE ACCORDING TO GUIDELINES MENTIONED BY DR HAHNEMANN IN APHORISMS NUMBER 83 TO 104 FURTHER CASE PROCESSING WILL BE DONE USING ZOMEO SOFTWARE OR BOOK FORM OF KNERR REPERTORY TO DIFFERENTIATE GROUP OF MEDICINES HERING GUIDING SYMPTOM OF OUR MATERIA MEDICA WILL BE USED CHOSEN REMEDY WILL BE GIVEN IN  VARIOUS POTENCY AS PER REQUIREMENT OF CASES. THE FOLLOW UP BE TAKEN USING RINGWORM SYMPTOM SCORE AT 7 15 OR 21 DAYS INTERVALAS PER CASE REQUIREMENT  AFTER CESSEATION OF TREATMENT PATIENT WILL BE FOLLOWED UP FOR AT LEAST 3 MONTHS TO CHECK RELAPSE ANALYSIS OF RESULT WILL BE DONE ACCORDING TO RESPONSE OBTAINED AFTER TREATMENT THE PERCENTAGE CRITERIA FOR PARTICULAR CASE WILL BE OBTAINED WITH USE OF RINGWORM SYMPTOM SCORE STATISTICAL ANALYSIS WILL BE DONE WITH PAIRED T-TEST THE EXPECTED RESULT WILL BE EITHER SIGNIFICANT OR NO USEFULNESS OF RUBRICS OF RINGWORM FROM KNERR REPERTORY IN TREATING THE CASES OF RINGWORM

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
10.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • DIAGNOSED CASES OR CASES WITH CLINICAL PRESENTATION OF RINGWORM.

排除标准

  • CASES OF RINGWORM WITH AIDS CASES OF RINGWORM COMPLICATED WITH OTHER SKIN COMPLAINT CASES OF RINGWORM WITH SEVERELY IMMUNOCOMPROMISED STATE CASES OF RINGWORM IN PREGNANT WOMEN.

结局指标

主要结局

RINGWORM SYMPTOM SCORE

时间窗: FOLLOW UP WILL BE TAKEN ON 7 15 21 DAYS AS PER CASE REQUIREMENT

次要结局

未报告次要终点

研究者

发起方
KHUSHALI KUBERBHAI PATEL
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验